Table of Contents - WOC 2012

PO-RET-134
Acute Retinal Necrosis After Boston Type I Keratoprosthesis (Case
Report)
Al Rashaed Saba (1) , Alamri, MD Abdullah (1) , Al Kharashi, MD Sulaiman (1)
1. King Khaled Eye Specialist Hospital
Objective: To demonstrate the safety and efficacy of prechopping with only two
viscoelastic cannulas avoiding the need of complimenary instrumentation.
Methods: Two randomized groups were operated of cataract surgery by a
single surgeon. One group (control) was operated with traditional in the bag
prechopping with prechop forceps, while the experimental group was operated
with prechopping with viscoelastic cannulas at the iris plane. Surgical variables
and postoperative outcomes were recorded in both gropups.
Results: No differences were found between the groups regarding surgical
complications and postoperative outcome. Only statistical difference was found
in the lesion to the capsular bag, maybe because the precopping maneuvers
within; the group with prechopping with cannulas at the iris plane, showed less
incidence of capsular bag damage.
Conclusion: Prechop with viscoelastic cannulas at the iris plane is a safe and
effective technique. It is also unexpensive.,
PO-RET-135
Idiopathic Polypoidal Choroidal Vasculopathy in a Young Man
Al Rashaed Saba (1)
1. King Khaled Eye Specialist Hospital
Purpose: To report a case of idiopathic polypoidal choroidal vasculopathy and
its angiographic characteristics in a young man. Method: Clinical data including
visual acuity, color fundus photography, uorescein angiograph and indocyanine
green results of this case were reviewed. Case: A 21-year-old Saudi healthy
man presented with sudden loss of vision in the left eye for 3 weeks duration.
Visual acuity in the right eye was 20/20 and in the left eye was 1/200. Fundus
examination of right eye was normal; however, in the left eye showed vitreous
hemorrhage with massive sub retinal yellowish old blood in the posterior pole
with epiretinal fresh blood on the fovea. Intra venous uorescein angiography
and indocyanine green tests showed features of idiopathic polypoidal choroidal
vasculopathy. Patient received photodynamic therapy twice without signicant
visual improvement.
Conclusion: Idiopathic polypoidal choroidal vasculopathy can occur in a young
age group and can lead to severe visual impairment. Key words: Idiopathic
polypoidal choroidal vasculopathy, young age, severe visual loss, photodynamic
therapy
PO-RET-136
Characteristics of Optic Disc Melanocytomas Presenting with Visual
Dysfunction
Al Rashaed Saba (1) , Nowilaty Sawsan (1) , Abboud Emad (1)
1. King Khaled Eye Specialist Hospital
Objective and Design: A retrospective review study was designed to describe
five cases of optic disc melanocytomas with tumor-related visual impairment.
Participants: Five patients with optic disc melanocytoma presented with visual
complaints to a tertiary eye hospital in Saudi Arabia. Materials and
Methods: Demographic and clinical data were analyzed, including the results
of ocular examination, lesion laterality, best-corrected Snellen visual acuity,
pupillary reflex, visual field testing, color fundus photography, fundus
fluorescein angiography, and ophthalmic ultrasound.
Results: Visual dysfunction secondary to optic disc melanocytoma was
identified. Case 1 had macular star edema with mild tumor enlargement,
Case 2 had optic atrophy, Case 3 had juxtapapillary choroidal neovascular
membrane with macular involvement, Case 4 had optic disc swelling with an
enlarged blind spot, and Case 5 had a large altitudinal visual field defect.
Conclusion: Although melanocytomas of the optic disc tend to have a benign
behavior with slow evolution and stable vision, they may adversely affect visual
function through a variety of mechanisms.
WOC2012 Abstract Book
PO-RET-137
Combined Intravitreal Bevacizumab with Photodynamic Therapy
Followed by a Tailored Re-treatment in Polypoidal Choroidal
Vasculopathy; Three-Year Results
Jeon Sohee (1) , Lee Won ki (1)
1. Seoul Saint Mary›s Hospital
PURPOSE: To evaluate the efficacy of initial combination therapy using
photodynamic therapy (PDT) and intravitreal bevacizumab (IVB), followed by a
tailored treatment for recurrent lesions.
Methods: Forty eyes of 38 patients were retrospectively reviewed. When
treating recurrent lesions, selective PDT and/or laser combined with IVB were
performed for polyps. Bevacizumab was given when there was no certain
polyp.
Results: The recurrent rates were 42.5%. The mean numbers of PDT, laser,
and IVB were 1.65, 0.1, and 5.93 respectively. The mean BCVA was 0.67
logMAR at baseline and 0.55 at 3 years.
Conclusions: This treatment strategy showed promising visual outcome, while
reducing PDT number.
PO-RET-138
Bevacizumab for serous changes originating From a Persistent
Branching Vascular Network After Following Photodynamic Therapy
for Polypoidal Choroidal Vasculopathy
Jeon Sohee (1) , Lee Won ki (1) , Kim Kyu Seop (1)
1. Seoul Saint Mary›s Hospital
Purpose: To report the efficacy of intravitreal bevacizumab for recurrent or
persistent serous changes originating from a persistent branching vascular
network or secondary choroidal neovascularization after photodynamic therapy
for polypoidal choroidal vasculopathy, despite regression of polypoidal lesions.
Methods: Twenty eyes of twenty patients with at least 12 months of regular
follow-up were retrospectively reviewed. Intravitreal bevacizumab was
administered on an as-needed basis, guided by optical coherence tomography
(OCT), after the first injection.
Results: Seventeen (85%) of 20 eyes showed resolution of macular fluid after
a mean of 1.9 (range 1-3) consecutive injections; however, fifteen (88%) of them
had relapsing episode(s) of fluid collection. The mean number of injections
needed were 4.2 (range 1-6) over a period of 12 months. At 12 months, 10
eyes (50%) had no fluid accumulation on OCT, while 10 eyes (50%) had some
residual fluid. The mean central foveal thickness improved significantly from
280±37 ?to 226±62 ? (P=0.002). Visual acuity was maintained or improved in
16 eyes (80%).
Conclusions: Intravitreal bevacizumab appears to be effective in resolving
intraretinal or and subretinal fluid originating from these lesions. However, the
favorable effect was maintained for only a limited period of time and required
repeated injections.
633